Efficacy and safety of anti-LAG-3 IBI110 in combination with sintilimab and chemotherapy for advanced squamous non-small cell lung cancer: a randomized phase II study
Authors
Zengmei Sheng
Donglin Wang
Zhiye Zhang
Zhe Liu
Jun Yang
Jian Fang
Caicun Zhou
Anwen Xiong
Sixiang Long
Tienan Yi
Wei Zuo
Chenyu Mao
Xiaobo Du
Lika Ye
Nong Xu
Wenxiang Wang
Jiuwei Cui
Qianyi Wang
Kunyu Yang
Wu Zhuang
Institutions
Nanchang University (CN)
Capital Medical University (CN)
Jilin University (CN)
Peking University (CN)
Second Affiliated Hospital of Guangzhou Medical University (CN)
Peking University Cancer Hospital (CN)
Mianyang Central Hospital (CN)
Beijing Chest Hospital (CN)
Hunan Cancer Hospital (CN)
Xiangyang Central Hospital (CN)
First Hospital of Jilin University (CN)
Shanghai East Hospital (CN)
First Affiliated Hospital of Henan University of Science and Technology (CN)
Suzhou Industrial Park Vocational Technical College (CN)
Fujian Provincial Cancer Hospital (CN)
Chongqing Cancer Hospital (CN)
Union Hospital (CN)
Third Hospital of Changsha (CN)
First Affiliated Hospital of Nanchang University (CN)
First Affiliated Hospital Zhejiang University (CN)
Efficacy and safety of anti-LAG-3 IBI110 in combination with sintilimab and chemotherapy for advanced squamous non-small cell lung cancer: a randomized phase II study
Zengmei Sheng, Donglin Wang, Zhiye Zhang, Zhe Liu et al.
Journal
Cancer Immunology Immunotherapy
Topics
Lung Cancer Treatments and Mutations
article
Efficacy and safety of anti-LAG-3 IBI110 in combination with sintilimab and chemotherapy for advanced squamous non-small cell lung cancer: a randomized phase II study
Zengmei Sheng, Donglin Wang, Zhiye Zhang, Zhe Liu, Jun Yang, Jian Fang, Caicun Zhou, Anwen Xiong, Sixiang Long, Tienan Yi, Wei Zuo, Chenyu Mao, Xiaobo Du, Lika Ye, Nong Xu, Wenxiang Wang, Jiuwei Cui, Qianyi Wang, Kunyu Yang, Wu Zhuang
article en
Abstract
No abstract available for this paper.
Publication Tag
Cancer Immunology ImmunotherapyVol. 75(2)
Institutions
Nanchang University (CN), Capital Medical University (CN), Jilin University (CN), Peking University (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Peking University Cancer Hospital (CN), Mianyang Central Hospital (CN), Beijing Chest Hospital (CN), Hunan Cancer Hospital (CN), Xiangyang Central Hospital (CN), First Hospital of Jilin University (CN), Shanghai East Hospital (CN), First Affiliated Hospital of Henan University of Science and Technology (CN), Suzhou Industrial Park Vocational Technical College (CN), Fujian Provincial Cancer Hospital (CN), Chongqing Cancer Hospital (CN), Union Hospital (CN), Third Hospital of Changsha (CN), First Affiliated Hospital of Nanchang University (CN), First Affiliated Hospital Zhejiang University (CN), Guangzhou Medical University (CN)